Welcome to GeneProof website!

It is great to see you here. To see all contents of the website, please register or restore your access.
We believe you will come back gladly.

GeneProof Team

 

User account
Forgot your password?
Searching
search

GeneProof SARS-CoV-2 PCR Kit

CE IVD New product
GeneProof SARS-CoV-2 PCR Kit

PRODUCT ADVANTAGES

 

TRIPLE TARGET DETECTION

  • Three independent targets in one tube
  • Avoids false negative results
  • Targets: RdRp gene, E gene, N gene (design recommended by WHO)


UNIQUE INTERNAL CONTROL CONSTRUCTION

  • Internal control imitates natural virus particle
  • Control of the whole diagnostic process including viral nucleoproteine lysis, RNA extraction, reverse transcription and PCR amplification
  • Enables full control of any non-isolation sample pretreatment
  • IC is included in the PCR kit
     

SINGLE TUBE READY-TO-USE MASTER MIX

  • Master Mix contains all components for PCR amplification
  • No additional pipetting of PCR reagents necessary
  • Significantly simplifies laboratory workflow
     

CONTAMINATION PREVENTION

  • Master Mix contains Uracil-DNA glycosylase (UNG) and dUTPs eliminating contamination with amplification products
     

MADE IN CZECH REPUBLIC

  • Developed and manufactured in the Czech Republic

 

COMPATIBLE WITH A WIDE RANGE OF REAL-TIME PCR DEVICES

CE IVD CERTIFIED DIAGNOSTIC TEST

Order information

Product name Catalog no. Technology Packaging
GeneProof SARS-CoV-2 PCR Kit COV2/GP/100 real-time PCR 100 reactions

EQA Panels

EQA results

GP_COV2_QCMD_2020_ EN
pdf, [201.23 kB]
open
Choose all

Technical specification

Technology real-time PCR
Type of Analysis qualitative
Target sequence specific region in RdRp gene, E gene and N gene
Analytical Specificity SARS-CoV-2, 100 %
Analytical Sensitivity (LoD with 95% Probability)

reaches up to 65.44 cp/μl using UNI PCR program (material quantified on standard 1 (SARS CoV
(Frankfurt 2003, EVAg,. Corman))
reaches up to 23.89 cp/μl using COVID SCREEN program (material quantified on standard 1 (SARS CoV
(Frankfurt 2003, EVAg,. Corman))
reaches up to 1.77 cp/μl using UNI PCR program on synthetic positive control
Extraction/Inhibition Control

PCR inhibition and RNA extraction efficiency control 
Validated Specimen swab, transport medium
Storage -20 ± 5 °C
Validated Extraction Methods croBEE NA16 Nucleic Acid Extraction System
GeneProof PathogenFree RNA Isolation Kit
GeneProof Universal Nucleic Acid Extraction Kit
Instruments

croBEE Real-Time PCR System
Applied Biosystems 7500 Real-Time PCR System
CFX96™/ Dx Real-Time PCR Detection System
LineGene 9600 Plus
SLAN® Real-Time PCR System
Required Detection Channels FAM, HEX, Cy5
External Quality Assessment Regularly tested by QCMD and INSTAND e.V. External Quality Assessment panels – results at www.geneproof.com
Certification CE IVD 

 

Documentation

Instruction for Use

Declaration of Verification of the kits with medical devices
pdf, [1.4 MB]
GP_COV2_Advisory_Notice_EN_CZ
pdf, [276.65 kB]
GP_COV2_Instruction for Use_CZ
pdf, [291.96 kB]
GP_COV2_Instruction for Use_EN
pdf, [254.32 kB]

Declaration of Conformity

GP_COV2_Declaration of Conformity_CZ
pdf, [294.8 kB]
GP_COV2_Declaration of Conformity_EN
pdf, [304.64 kB]

MSDS

GP_Safety Data Sheet_CZ
pdf, [134.4 kB]
GP_Safety Data Sheet_EN
pdf, [148.84 kB]

Manual

croBEE Real-Time PCR System_CZ
pdf, [6.09 MB]
croBEE Real-Time PCR System_EN
pdf, [5.9 MB]

Product Leaflet

GP_COV2_Leaflet_CZ
pdf, [426.45 kB]
GP_COV2_Leaflet_EN
pdf, [426.72 kB]

PCR Template

GP_COV2_ABI7500
edt, [10.33 kB]
GP_COV2_CFX
prcl, [1.35 kB]
GP_COV2_croBEE
fqt, [4.97 kB]
GP_COV2_LC480
ixo, [9.5 kB]
GP_COV2_RG
ret, [14.88 kB]
Files are available only for registered users.

Gallery

zvětšit
GP_SARS_CoV_2_PCR_Kit

Order

+420 543 211 679
sales@geneproof.com

Technical Support 

Contact form 
+420 730 176 222
support@geneproof.com

FAQ

 

 

News

Gregor Johann Mendel was born on this day 198 years ago.

Gregor Johann Mendel - Father of Genetics. 

Success of GeneProof SARS-CoV-2 in QCMD

Both GeneProof PCR kits detecting SARS-CoV-2 successfully participated in QCMD panels. GeneProof SARS-CoV-2…

more